About this programme

The concrete goal of access to risk finance under Horizon 2020 is to support and facilitate access to sources of debt and equity financing by innovative companies of all sizes and also by research centers and universities etc.

This support is given through financial intermediaries.

 

Click to read more 
Hide text 

Your NCP contacts for this programme

No dedicated person at the moment

Please contact

info@ncpflanders.be

+32 2 550 15 65

Your PC contact for this programme

Find the contact info on the site of WEWIS

The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.

The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.

Latest news

Upcoming events

No events that are specifically related to Access to risk finance were found. Check the full calendar.

Infosheets

Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.

    No infosheets available for this domain

Related links

Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.

Documents

Documents contain additional information related to this programme, and are similar to related links.

Testimonial

image of SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.